DBD stock

Diebold Nixdorf, Incorporated (DBD) support and resistance · P/E 28, rev $3.75B

Diebold Nixdorf, Incorporated (DBD) is a software - application company listed on US.

This page maps Diebold Nixdorf, Incorporated (DBD) support and resistance from cached range and valuation — not a live tape and not a trade alert.

Latest reported DBD revenue for 2024-12-31 was $3.75B. Net income was -$14.5M. Revenue was up 130.3% from 2023-12-31 to 2024-12-31. DBD currently screens at market cap $2.82B and trailing P/E 28.1.

DBD currently screens at market cap $2.82B and trailing P/E 28.1. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.

A new DBD 8-K or 10-Q can move the levels that matter more than a drawing on a chart.

Not investment advice. Use the DBD quote page for the session range and the stock page for the full model.

Not investment advice.

Full DBD analysis